LB Pharmaceuticals LBRX
Ownership & positioning
Who holds it, who is betting against it, and where the big money is moving
Short-sale volume as % of daily volume
Large-order net flow, last 20 sessions
Net of large-order buying minus selling, in USD. Over this window: +$5.02M (13 inflow days, 7 outflow days).
Net flow by order size, last 20 sessions
Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.
The five largest holders on file together own 33.8% of shares outstanding.
Largest holders
By investor type
Reported short interest has risen from 15.98% to 19.22% of float over the last 6 biweekly reports (14 Aug 2026 to 30 Oct 2026).
Recent institutional activity
| Holder | Type | Period | Share change | New stake |
|---|---|---|---|---|
| FMR | Mutual Fund | 2026/Q3 | +915,005 | 3.4% |
| Candriam, Société En Commandite Par Actions | Mutual Fund | 2026/Q3 | +284,233 | 0.9% |
| UBS Asset Management | Mutual Fund | 2026/Q3 | +135,195 | 0.7% |
| Vanguard Capital Management, LLC | Mutual Fund | 2026/Q3 | +128,715 | 3.4% |
| State Street Global Advisors | Mutual Fund | 2026/Q3 | +103,377 | 2.2% |
| BNP Paribas Financial Markets SNC | Private Company | 2026/Q3 | +80,710 | 0.5% |
| Morgan Stanley | Public Company | 2026/Q3 | +65,225 | 0.4% |
| Morgan Stanley Investment Management Inc. | Mutual Fund | 2026/Q3 | +65,225 | 0.4% |
| JPMorgan Chase & Co. | Public Company | 2026/Q3 | +49,625 | 0.3% |
| Invesco Capital Management LLC | Mutual Fund | 2026/Q3 | +36,420 | 0.1% |
| Nuveen Asset Management LLC | Insurance Company | 2026/Q3 | +45,220 | 0.1% |
| Boothbay Fund Management, LLC | Hedge Fund | 2026/Q3 | +275,675 | 0.9% |
| BlackRock | Mutual Fund | 2026/Q3 | +263,460 | 8.5% |
| Trails Edge Capital Partners, LP | Hedge Fund | 2026/Q3 | +203,660 | 4.7% |
| The Goldman Sachs Group, Inc. | Public Company | 2026/Q3 | +201,423 | 1.8% |
Institutional buy/sell activity by reporting period, largest moves first.
Insider transactions
| Date | Insider | Title | Transaction | Shares | Price | Held after |
|---|---|---|---|---|---|---|
| 8 Oct 2026 | Joseph Miller | Chief Financial Officer | Other Derivative Acquisition | +200,000 | $37.22 | 200,000 |
| 8 Oct 2026 | Susan Kozauer | Chief Medical Officer | Other Derivative Acquisition | +200,000 | $37.22 | 200,000 |
| 29 Jul 2026 | David Kroin | Open Market Derivative Acquisiti | +286,205 | $0.00 | 664,649 | |
| 8 Jun 2026 | Zachary Prensky | Intent to Sell (Form 144) | -16,500 | $29.49 | – | |
| 2 Jun 2026 | Robert Richard Ruffolo | Independent Director | Other Derivative Acquisition | +10,000 | $27.95 | 10,000 |
| 2 Jun 2026 | Ran Nussbaum | Independent Director | Other Derivative Acquisition | +10,000 | $27.95 | 10,000 |
| 2 Jun 2026 | William Kane | Independent Director | Other Derivative Acquisition | +10,000 | $27.95 | 10,000 |
| 2 Jun 2026 | Scott Garland | Independent Chairperson | Other Derivative Acquisition | +10,000 | $27.95 | 10,000 |
| 2 Jun 2026 | Rebecca Luse | Independent Director | Other Derivative Acquisition | +10,000 | $27.95 | 10,000 |
| 2 Jun 2026 | Rekha Hemrajani | Independent Director | Other Derivative Acquisition | +10,000 | $27.95 | 10,000 |
| 2 Jun 2026 | Robert Lenz | Independent Director | Other Derivative Acquisition | +12,500 | $27.95 | 12,500 |
| 5 Mar 2026 | Robert Lenz | Independent Director | Other Derivative Acquisition | +20,000 | $23.78 | 20,000 |
| 5 Feb 2026 | Deep Track Capital, LP | Open Market Derivative Acquisiti | +472,369 | $0.00 | 93,925 | |
| 9 Dec 2025 | Kaya Pai Panandiker | Chief Commercial Officer | Other Derivative Acquisition | +195,000 | $21.36 | 195,000 |
| 11 Sep 2025 | Pontifax Venture Capital | Private Acquisition | +1,000,000 | $15.00 | 1,000,000 | |
| 11 Sep 2025 | Pontifax Venture Capital | Derivative Exercise and Retained | +411,681 | – | 1,000,000 | |
| 11 Sep 2025 | Deep Track Capital, LP | Private Acquisition | +2,666,666 | $15.00 | 666,666 | |
| 11 Sep 2025 | Deep Track Capital, LP | Derivative Exercise and Retained | +686,138 | – | 666,666 | |
| 11 Sep 2025 | Deep Track Capital, LP | Initial Statement of Beneficial | +0 | – | 666,666 | |
| 9 Sep 2025 | Robert Richard Ruffolo | Independent Director | Derivative Sale to Issuer | -13,266 | – | – |
From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.
Short interest, by report
| Report date | Shares short | % of float | Days to cover |
|---|---|---|---|
| 30 Oct 2026 | 6,199,068 | 19.2% | 18.0 |
| 15 Oct 2026 | 5,564,315 | 17.2% | 12.1 |
| 30 Sep 2026 | 6,010,646 | 18.6% | 14.5 |
| 15 Sep 2026 | 5,617,182 | 17.4% | 21.5 |
| 31 Aug 2026 | 5,278,529 | 16.4% | 19.9 |
| 14 Aug 2026 | 5,156,413 | 16.0% | 12.4 |
No comments yet — be the first to weigh in on LBRX.
Sign in to join the discussion.